Veru announces mitchell steiner as keynote speaker at biomed israel 2024: the 22nd national life science & technology week

Miami, fl, may 14, 2024 (globe newswire) -- veru inc. (nasdaq: veru), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced that mitchell steiner, m.d., chairman, president, and chief executive officer, will be a keynote speaker at biomed israel 2024: the 22nd national life science & technology week, taking place may 21-23, 2024, in tel aviv, israel.
VERU Ratings Summary
VERU Quant Ranking